Cargando…

Processing Newborn Bloodspot Screening Results for CF

Every newborn bloodspot screening (NBS) result for cystic fibrosis (CF) consists of two parts: a screening part in the laboratory and a clinical part in a CF centre. When introducing an NBS programme, more attention is usually paid to the laboratory part, especially which algorithm is most suitable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barben, Jürg, Chudleigh, Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422987/ https://www.ncbi.nlm.nih.gov/pubmed/33073022 http://dx.doi.org/10.3390/ijns6020025

Ejemplares similares

Process evaluation of co-designed interventions to improve communication of positive newborn bloodspot screening results
por: Chudleigh, Jane, et al.
Publicado: (2021)

Co-designing Improved Communication of Newborn Bloodspot Screening Results to Parents: Mixed Methods Study
por: Chudleigh, Jane, et al.
Publicado: (2022)

Qualitative exploration of health professionals’ experiences of communicating positive newborn bloodspot screening results for nine conditions in England
por: Chudleigh, Jane, et al.
Publicado: (2020)

Newborn bloodspot screening in the time of COVID-19
por: Greaves, Ronda F., et al.
Publicado: (2021)

Parents’ views on accepting, declining, and expanding newborn bloodspot screening
por: van der Pal, Sylvia M., et al.
Publicado: (2022)

Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis
por: Armstrong, Rachael E., et al.
Publicado: (2020)

Parental Decision-Making and Acceptance of Newborn Bloodspot Screening: An Exploratory Study
por: Nicholls, Stuart G., et al.
Publicado: (2013)

Understanding Midwives’ Preferences for Providing Information About Newborn Bloodspot Screening
por: Wright, Stuart James, et al.
Publicado: (2018)

The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review
por: Wright, Stuart J., et al.
Publicado: (2015)

Psychological Impact of NBS for CF
por: Chudleigh, Jane, et al.
Publicado: (2020)

International Approaches to Management of CFTR-Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis
por: Chudleigh, Jane, et al.
Publicado: (2022)

Secondary research uses of residual newborn screening dried bloodspots: a scoping review
por: Rothwell, Erin, et al.
Publicado: (2018)

Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders
por: Boychuk, Natalie A., et al.
Publicado: (2022)

Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005–7
por: Streetly, A, et al.
Publicado: (2009)

Why Do We Screen Newborn Infants for Cystic Fibrosis?
por: Barben, Jürg, et al.
Publicado: (2020)

Processing of Positive Newborn Screening Results for Congenital Hypothyroidism: A Qualitative Exploration of Current Practice in England
por: Holder, Pru, et al.
Publicado: (2021)

Longitudinal metabolomics in dried bloodspots yields profiles informing newborn screening for succinic semialdehyde dehydrogenase deficiency
por: Brown, Madalyn, et al.
Publicado: (2020)

Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol
por: Nicholls, S G, et al.
Publicado: (2014)

Newborn Screening for CF across the Globe—Where Is It Worthwhile?
por: Scotet, Virginie, et al.
Publicado: (2020)

Variability in the storage and use of newborn dried bloodspots in Canada: is it time for national standards?
por: Avard, Denise, et al.
Publicado: (2006)

Assessing a New Method for Measuring Fetal Exposure to Mercury: Newborn Bloodspots
por: Nelson, Jessica W., et al.
Publicado: (2016)

The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism
por: Bessey, Alice, et al.
Publicado: (2020)

Psychological Impact on Parents of an Inconclusive Diagnosis Following Newborn Bloodspot Screening for Cystic Fibrosis: A Qualitative Study
por: Johnson, Faye, et al.
Publicado: (2019)

Policy-making and implementation for newborn bloodspot screening in Europe: a comparison between EURORDIS principles and UK practice
por: Lombardo, Silvia, et al.
Publicado: (2023)

Parental Awareness, Knowledge, and Attitudes Regarding Current and Future Newborn Bloodspot Screening: The First Report from Thailand
por: Wilaiwongsathien, Kalyarat, et al.
Publicado: (2023)

Processing of positive newborn screening results: a qualitative exploration of current practice in England
por: Chudleigh, Jane, et al.
Publicado: (2020)

Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective
por: van Dijk, Tessa, et al.
Publicado: (2021)

What Mothers Know about Newborn Bloodspot Screening and the Sources They Use to Acquire This Knowledge: A Pilot Study in Flanders
por: di Gangi, Caroline, et al.
Publicado: (2023)

Influence of maternal socioeconomic deprivation and living environment on newborn bloodspot 25-hydroxyvitamin D levels
por: Högler, Wolfgang, et al.
Publicado: (2022)

Concurrent newborn hearing and genetic screening of common hearing loss variants with bloodspot-based targeted next generation sequencing in Jiangxi province
por: Luo, Haiyan, et al.
Publicado: (2022)

60: The real-world effectiveness of U.S. CF newborn screening
por: Rosenfeld, M., et al.
Publicado: (2021)

Expanded Neonatal Bloodspot Screening Programmes: An Evaluation Framework to Discuss New Conditions With Stakeholders
por: Jansen, Marleen E., et al.
Publicado: (2021)

Parents’ Experiences of Receiving the Initial Positive Newborn Screening (NBS) Result for Cystic Fibrosis and Sickle Cell Disease
por: Chudleigh, Jane, et al.
Publicado: (2016)

Association between Several Persistent Organic Pollutants and Thyroid Hormone Levels in Cord Blood Serum and Bloodspot of the Newborn Infants of Korea
por: Kim, Sunmi, et al.
Publicado: (2015)

Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: An available high-throughput liquid-chromatography tandem mass spectrometry method
por: Bleyle, Lisa, et al.
Publicado: (2016)

Rethinking Strategies for Positive Newborn Screening Result (NBS+) Delivery (ReSPoND): a process evaluation of co-designing interventions to minimise impact on parental emotional well-being and stress
por: Chudleigh, Jane, et al.
Publicado: (2019)

Neonatal Lead (Pb) Exposure and DNA Methylation Profiles in Dried Bloodspots
por: Montrose, Luke, et al.
Publicado: (2020)

Methyl-CpG-Binding PCR of Bloodspots for Confirmation of Fragile X Syndrome in Males
por: Tzeng, Ching-Cherng, et al.
Publicado: (2009)

Delivering Positive Newborn Screening Results: Cost Analysis of Existing Practice versus Innovative, Co-Designed Strategies from the ReSPoND Study
por: Fusco, Francesco, et al.
Publicado: (2022)

Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants
por: Nguyen, The Thanh-Diem, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3nkm83bjaddn0aeqv09p95071b